AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|AAPL329.89-3.19 (-0.96%) ▼|ABBV262.61+0.84 (+0.32%) ▲|ABT101.85-1.24 (-1.20%) ▼|ACN196.97+1.97 (+1.01%) ▲|ADBE263.14-2.46 (-0.93%) ▼|AMAT418.01-6.21 (-1.46%) ▼|AMD503.78+10.37 (+2.10%) ▲|AMGN378.07-3.43 (-0.90%) ▼|AMT177.02+0.08 (+0.05%) ▲|AMZN248.57-4.97 (-1.96%) ▼|AVGO338.56-6.16 (-1.79%) ▼|AXP324.25-3.53 (-1.08%) ▼|BA210.81+0.54 (+0.25%) ▲|BAC59.53+0.06 (+0.09%) ▲|BKNG171.48-3.87 (-2.21%) ▼|BLK1,054.53-11.07 (-1.04%) ▼|BMY63.77-0.33 (-0.51%) ▼|BNY155.08-2.58 (-1.64%) ▼|BRK-B514.82-0.13 (-0.03%) ▼|C135.48-0.71 (-0.52%) ▼|CAT784.42+0.42 (+0.05%) ▲|CL87.27-0.62 (-0.71%) ▼|CMCSA24.64-0.25 (-0.98%) ▼|COF206.21-0.47 (-0.23%) ▼|COP141.42+4.75 (+3.47%) ▲|COST908.25-10.66 (-1.16%) ▼|CRM259.90+0.47 (+0.18%) ▲|CSCO109.96-0.11 (-0.10%) ▼|CVS94.68-0.87 (-0.91%) ▼|CVX216.90+4.73 (+2.23%) ▲|DE688.12+6.66 (+0.98%) ▲|DHR207.33+4.08 (+2.01%) ▲|DIS107.39-1.20 (-1.11%) ▼|DUK118.11-0.91 (-0.76%) ▼|EMR146.92-1.38 (-0.93%) ▼|FDX309.38-3.19 (-1.02%) ▼|GD357.96+1.15 (+0.32%) ▲|GE309.33-8.23 (-2.59%) ▼|GEV879.12+4.36 (+0.50%) ▲|GILD145.45-0.14 (-0.10%) ▼|GM85.64-1.52 (-1.74%) ▼|GOOG339.69-6.02 (-1.74%) ▼|GOOGL343.19-6.20 (-1.77%) ▼|GS960.68-27.77 (-2.81%) ▼|HD307.53-3.34 (-1.07%) ▼|HON200.72-0.66 (-0.33%) ▼|IBM250.64+1.55 (+0.62%) ▲|INTC97.67+0.48 (+0.49%) ▲|INTU337.51-1.64 (-0.48%) ▼|ISRG376.82-1.12 (-0.30%) ▼|JNJ264.65-1.68 (-0.63%) ▼|JPM345.28-4.85 (-1.39%) ▼|KO88.45-0.38 (-0.42%) ▼|LIN462.65-1.76 (-0.38%) ▼|LLY1,141.46+3.18 (+0.28%) ▲|LMT533.64+4.26 (+0.80%) ▲|LOW195.46-2.71 (-1.37%) ▼|LRCX267.16-6.33 (-2.31%) ▼|MA571.70-2.72 (-0.47%) ▼|MCD254.19-3.30 (-1.28%) ▼|MDLZ62.15-0.25 (-0.39%) ▼|MDT94.03+0.23 (+0.25%) ▲|META666.36+0.76 (+0.11%) ▲|MMM164.31+2.29 (+1.41%) ▲|MO70.13+0.63 (+0.90%) ▲|MRK143.63-0.37 (-0.26%) ▼|MS202.75-3.84 (-1.86%) ▼|MSFT499.41-6.00 (-1.19%) ▼|MU924.85+0.82 (+0.09%) ▲|NEE81.61-0.03 (-0.03%) ▼|NFLX78.33-1.99 (-2.48%) ▼|NKE36.43-0.62 (-1.67%) ▼|NOW145.11+2.76 (+1.94%) ▲|NVDA211.67+0.71 (+0.34%) ▲|ORCL143.08-1.71 (-1.18%) ▼|PEP135.46-0.88 (-0.65%) ▼|PFE27.49-0.24 (-0.85%) ▼|PG147.08+0.95 (+0.65%) ▲|PLTR176.17+2.86 (+1.65%) ▲|PM193.19-1.68 (-0.86%) ▼|QCOM188.57+8.42 (+4.67%) ▲|RTX195.71+0.37 (+0.19%) ▲|SBUX96.62-2.46 (-2.48%) ▼|SCHW108.19+0.88 (+0.82%) ▲|SO86.29-0.71 (-0.82%) ▼|SPG203.98-0.99 (-0.48%) ▼|T26.82+0.31 (+1.17%) ▲|TMO636.22+23.07 (+3.76%) ▲|TMUS181.40-1.50 (-0.82%) ▼|TSLA357.10-1.88 (-0.52%) ▼|TXN263.61+0.19 (+0.07%) ▲|UBER71.93-0.70 (-0.96%) ▼|UNH376.31-7.24 (-1.89%) ▼|UNP284.83-0.25 (-0.09%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.28-0.40 (-0.64%) ▼|V374.81-0.47 (-0.13%) ▼|VZ51.57+0.28 (+0.55%) ▲|WFC89.07+0.36 (+0.41%) ▲|WMT108.70-0.38 (-0.35%) ▼|XOM169.31+4.23 (+2.56%) ▲|
22.6 C
New York
Tuesday, September 15, 2026

Tag: board

newssourceFORcompanyinformationcontent1releasesmarket

SRPT STOCK LOSS: Sarepta Therapeutics, Inc. Shareholders are Alerted of Ongoing Securities Fraud Investigation — Contact BFA Law (NASDAQ:SRPT)

Sarepta Therapeutics, Inc. investors that lost money are notified to contact BFA Law about its ongoing securities fraud investigation.

TAG1 and PharmaLogic Announce Strategic Partnership to Advance Decentralized Lead-212 Generator Development

Collaboration accelerates TAG1's Pb-212 generator development and supports PharmaLogic's mission to scale radiopharmaceutical innovation. ST. LOUIS, June 24, 2025 /PRNewswire/ -- TAG1 Inc., a premier...

OUTCROP SILVER ADDS THIRD DRILL RIG AT SANTA ANA TO EXPAND DISCOVERY POTENTIAL BEYOND CURRENT RESOURCE UPDATE

VANCOUVER, BC, June 24, 2025 /CNW/ - Outcrop Silver & Gold Corporation (TSXV: OCG) (OTCQX: OCGSF) (DE: MRG) ("Outcrop Silver") is pleased to announce the addition...

Enfuse Group Secures Strategic Investment from Agathos to Power Next Phase of Growth

LONDON, June 24, 2025 /PRNewswire/ -- Enfuse Group, a leading digital transformation consultancy and certified B Corp, is delighted to announce a strategic investment...

Golden Arrow Options Third Project in Argentina

TSX Venture Exchange (TSX-V): GRGFrankfurt Stock Exchange (FSE): G6AOTCQB Venture Market (OTCQB): GARWF VANCOUVER, BC, June 24, 2025 /PRNewswire/ - Golden Arrow Resources Corporation (TSXV: GRG) (FSE:...

Abitibi Metals Expands Mid-Level High-Grade Copper Zones at B26: 4.8% CuEq Over 4.1m within 63.2m at 1% CuEq

Highlights: Results from targeted drilling which expanded high-grade areas of the B26 Deposit: Hole 1274-25-363 – 1% CuEq over 63.2 metres beginning at 412.3 metres depth,...

Golden Arrow Options Third Project in Argentina

TSX Venture Exchange (TSX-V): GRGFrankfurt Stock Exchange (FSE): G6AOTCQB Venture Market (OTCQB): GARWF VANCOUVER, BC, June 24, 2025 /CNW/ - Golden Arrow Resources Corporation (TSXV: GRG) (FSE:...

Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt...

BOSTON, June 24, 2025 /PRNewswire/ -- Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced the appointment of Murray...

Abcentra Announces Appointment of Dr. Peter Libby as a Board Member as it Enters Orticumab’s Phase 2b Trial (FORTIFY)

LOS ANGELES, June 24, 2025 /PRNewswire/ -- Abcentra LLC (Abcentra), a clinical stage biotechnology company specializing in coronary artery disease, today announced the appointment...

Blues Welcomes Silicon Valley Veteran Ian Small as CEO to Deepen Customer Focus and Drive Expansion

BOSTON, June 24, 2025 /PRNewswire/ -- Blues, a leader in IoT connectivity solutions, today announced that former Evernote Chief Executive Officer (CEO) Ian Small has...

Tims China Announces First Quarter 2025 Financial Results

System Sales Increased 3.5% Year-over-Year to RMB376.3 Million

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

Breye Therapeutics announces successful completion of its Phase 1b trial with danegaptide in patients with diabetic retinopathy

Orally administered treatment was well tolerated, with early signs of clinical activityIn models of non-proliferative diabetic retinopathy (NPDR), danegaptide has demonstrated protection against retinal...

Hapbee Technologies Inc. Closes 2024 with Record Q4 Device Sales, Global Distribution Partnerships and Strategic Board Appointments

Fueled by a 198% surge in Q4 device sales revenue and a 200% increase in shipments, Hapbee’s revitalized marketing strategy, expanded retail footprint, luxury spa partnerships, and high-profile Board additions have set the stage for accelerated growth heading into 2025.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBoard

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers